scholarly journals Emergency use of Physician-modified Fenestrated Endograft in a Symptomatic Patient Who was Waiting for a Manufactured Graft to Treat Chronic Post-dissection Thoracoabdominal Aneurysm

2019 ◽  
Vol 58 (6) ◽  
pp. e372-e373
Author(s):  
Aleem K. Mirza ◽  
Jussi M. Kärkkäinen ◽  
Emanuel R. Tenorio ◽  
Nishant Saran ◽  
Gustavo S. Oderich
2013 ◽  
Author(s):  
Naveed U. Saqib ◽  
Robert Y. Rhee

The prevalence of descending thoracic aortic aneurysms (DTAs) and thoracoabdominal aortic aneurysms (TAAAs) are described. Imaging techniques and classification is given. Preoperative evaluation is described in detail, as prior to proceeding with repair of a DTA or a TAAA, patients must be thoroughly evaluated medically to determine if they are physiologically fit enough for repair. Indications for repair, primarily relating to size of aneurysm, are listed for both DTAs and TAAAs. Repair options and management for DTAs now includes thoracic endovascular aortic repair (TEVAR); its outcomes, benefits, and drawbacks are discussed in detail. The discussion of TAAAs is similar, with indications for repair and surgical management options given: direct open repair; a debranching procedure with subsequent endograft repair; and branched or fenestrated endograft repair. A table lists the symptoms attributable to thoracic and thoracoabdominal aortic aneurysms. Figures show the classification of DTAs; the evaluation of a patient with a thoracic aortic aneurysm; available thoracic endografts; anatomic restrictions for TEVAR; evaluation of a patient with a thoracoabdominal aneurysm; regional spinal cord hypothermic protection; distal aortic perfusion; visceral artery bypass; and a branched endograft.  This review contains 8 figures, 3 tables, and 125 references.


2019 ◽  
Vol 54 ◽  
pp. 337.e1-337.e4 ◽  
Author(s):  
Enrico Maria Marone ◽  
Luigi Federico Rinaldi ◽  
Domenico Antonio Diaco ◽  
Angelo Argenteri

2000 ◽  
Vol 7 (6) ◽  
pp. 513-519 ◽  
Author(s):  
Michael Lawrence-Brown ◽  
Kishore Sieunarine ◽  
Greg van Schie ◽  
Stephen Purchas ◽  
David Hartley ◽  
...  

2020 ◽  
Vol 11 (SPL1) ◽  
pp. 1208-1212
Author(s):  
Amol Madhav Deshpande ◽  
Mayuri Amol Deshpande

In last two decade world suffer with three epidemic diseases like SARS-CoV, H1N1 influenza, MERS –CoV and presently the world under a pandemic of Covid-19, out of these SARS-CoV, MERS –CoV and Covid-19 are form the same virus call as corona, which primary present on bats and transferred from animal to human, and then it transfer from human to human mostly by respiratory droplets or in the direct contact with the diseased person, these recurrent infection of corona virus is the burning issue in the word, so to avoid these recurrent infections good habitual behaviour with regular immune booster medicine should be taken which can be used in both normal and symptomatic patient for this Rasayan churna  is the best drug of choice as it is used for  rejuvenation therapy. From literally study from various recourses it is found that Rasayan churna have property anti-depressant, anti-xylotic, Immunomodulatory, Anti-diabetes, anti hypertensive, anti-inflammatory, Anti-toxic effects, Anti-arthritic, Anti-cancer effects, Anti-microbial effect, and Anti-oxidant which can be useful in preventive aspect of Covid -19 in all phase like normal individual, also can be used in asymptomatic patients and symptomatic patients, clinical study can be performed for the same to evaluate the result.


Author(s):  
M. R. Muehler ◽  
V. R. Rendell ◽  
L. L. Bergmann ◽  
E. R. Winslow ◽  
S. B. Reeder

Abstract Objectives Ferumoxytol is an ultra-small superparamagnetic iron oxide (USPIO) agent that is taken up by splenic tissue. This study describes our initial institutional experience of ferumoxytol-enhanced MRI (feMRI) for differentiating intrapancreatic splenules (IPS) from other pancreatic lesions. Methods In this retrospective study, patients with computed tomographic imaging that identified small enhancing lesions in the tail of the pancreas subsequently underwent feMRI for further characterization. The feMRI protocol included T2-weighted (T2w) imaging with and without fat suppression (FS), R2* mapping, diffusion-weighted imaging (DWI), and T1-weighted (T1w) imaging with FS, prior to contrast injection. Immediately after slow intravenous infusion with 3 mg/kg body weight ferumoxytol, T1w was repeated. Delayed imaging with all sequences were obtained 24–72 h after ferumoxytol administration. Results Seven patients underwent feMRI. In two patients, the pancreatic lesions were presumed as pancreatic neuroendocrine tumor (PNET) from feMRI and in the remaining 5 IPS. One of the two patients with PNET was symptomatic for NET. In another symptomatic patient with pathologically proven duodenal NET and suspected PNET, the pancreatic lesion was proven to be an IPS on feMRI. IPS demonstrated strong negative enhancement in feMRI on T2w and increased R2* values consistent with splenic tissue, while the presumed PNETs did not enhance. T2w FS was helpful on the pre-contrast images to identify IPS, while R2* did on post-contrast images. Neither DWI nor T1w contributed to differentiating PNETs from IPS. Conclusions This study demonstrates the potential utility of feMRI as a helpful adjunct diagnostic tool for differentiating IPS from other pancreatic lesions. Further studies in larger patient cohorts are needed.


Sign in / Sign up

Export Citation Format

Share Document